Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 26 results found. Search for [ Divi's Labs ]

Results 1 to 21 of 26
BusinessToday.In
April 3, 2020
Sensex, Nifty Live News Today:The 30-share index BSE Sensex fell 700 points lower at 27,550 and 50-share barometer NSE Nifty fell 176 points to 8,076.


BusinessToday.In
April 1, 2020
Share price of Divi's Labs closed at Rs 1,881 on Wednesday, declining 5.34% or 106 points on BSE.


BusinessToday.In
April 1, 2020
Sensex, Nifty Live News Today: In March month, Sensex and Nifty have declined by 25%. The coronavirus is guaranteed to throw the world into recession, and economists are becoming less convinced about the potential for a strong snapback in growth.


Rupa Burman Roy
March 5, 2020
Barring shares of Piramal Enterprises that fell around 0.3%, all the 9 other healthcare shares were trading higher on Nifty Pharma, that was up 0.78% at 8,200.


BusinessToday.In
March 5, 2020
Share Market Update: BSE 30-share S&P Sensex closed 61 points higher at 38,470 and Nifty50 ended 18 points higher at 11,269


BusinessToday.In
February 10, 2020
Share Market Update: BSE 30-share S&P Sensex ended 164 points lower at 40,979 and NSE 50-share index Nifty50 closed 66 points lower at 12,031.


BT Online
November 2, 2017
While the Sensex fell 0.08 percent or 27 points to 33,573 level, the Nifty fell 16.70 points or 0.16 percent to 10,423 level. The S&P BSE healthcare index rose 2.48 percent or 353.24 points at 14,611 level after other pharma stocks rose due to positive sentiment emanating from the Divi's Laboratories development.


Rajeev Dubey
Delhi, May 1, 2017
A group of inheritors takes charge with new ideas and new strategies


BT Online
New Delhi, March 22, 2017
The S&P BSE Sensex ended at 29,167.68, falling 317.77 points while the NSE Nifty ended at 9,030.45, down 91.05 points.


E Kumar Sharma
New Delhi, March 21, 2017
Shares of Divi's Laboratories hit a 52-week low of Rs 635 on Tuesday after the company informed BSE that USFDA had issued them an import alert on 20th March, for the products manufactured at their unit at Visakhapatnam, Andhra Pradesh.


BT Online
New Delhi, March 21, 2017
The Indian benchmark indices ended in red with Pharma stocks being the major laggards.


BT Online
December 26, 2016
While Sensex fell over 250 points or 1 percent to 25,791 points, Nifty fell over 1 per cent or 80 points to 7906 level. Nifty was trading at its seven month low, its lowest level since May 26, 2016.


BT Online
December 23, 2016
The Sensex which opened in the negative territory at 25959 level recovered ground and hit an intra-day high of 26,143 level and intra day low of 25,872 level.


P.B. Jayakumar, E. Kumar Sharma and Venkatesha Babu
June 17, 2015
Most of them started with very little capital and resources. And all of them persevered through the bad times of the industry.


E. Kumar Sharma
September 18, 2014
Not all Indian bulk drug makers are reeling before the Chinese onslaught. Some have honed their processes to become world leaders in niche areas.


PTI
New York, May 22, 2014
As many as nine Indian firms have made it to the Forbes Worlds 100 most innovative growth companies list, which has been topped by New Zealand software accounting firm Xero.


PTI
New Delhi, September 23, 2013
Sun TV promoters Kalanithi Maran and his wife Kavery were the top paid corporates in India in the last fiscal with a package of Rs 56.25 crore each among the listed companies, replacing Jindal Steel's Naveen Jindal from the pole position.


Tanvi Varma/Money Today
July 29, 2013
Include stocks in the sectors that might gain from the rupee's fall. These include pharmaceutical and information technology that earn a big part of their revenues in dollars.


L Kishore Babu
June 3, 2013
Although the industry had time until 2005 to conform to the new patent regime, we consciously avoided short-term temptations,  says L. Kishore Babu, CFO, Divi's Labs.


E. Kumar Sharma
March 25, 2013
K. Anji Reddy founded what is today one of India's biggest drug companies, but his larger contribution was his focus on research and development.


PAGES 1 OF 2  12